MKI67 and neuroendocrine neoplasm: Since a highly characteristic malignant marker (say 90% accuracy) has not been found in any neuroendocrine tumors, we therefore developed an integrated medical decision machine using a number of associated markers to predict malignancies and to diagnose different adrenocortical diseases, using FHIT, Ki-67 and PCNA as features in the input space.